from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2594c/ruvC

LFCtreatmentdescriptionclass of inhibitor

-0.204

Amikacinug/mL Amikacintranslation

0.040

Cap5-10ug/mL Capreomycintranslation

0.642

Rox10-50 ug/mL Roxithromycintranslation

-0.319

SM2-5 ug/mL Streptomycintranslation

0.652

Tet5-10 ug/mL Tetracyclinetranslation

-1.432

Rif0.2-5ug/mL Rifampicintranscription

-1.109

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.077

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.009

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.463

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.108

Clofazimine10-13 ug/mL Clofaziminerespiration

0.017

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.484

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.508

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.102

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.184

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.766

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.601

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.286

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.440

KCN5-20 ug/mL Potassium cyaniderespiration

-0.294

NaN30.2-2 mM Sodium aziderespiration

-1.122

Nigericin50 uM Nigericinrespiration

-0.882

TRC10-150 ug/mL Triclosanrespiration

-0.377

TRZ10-25 ug/mL Thioridazinerespiration

-0.608

Valinomycin0.5-10 uM Valinomycinrespiration

-0.330

ZnSO42 mM ZnSO4respiration

-0.976

menadione6-10 ug/mL Menadionerespiration

-0.100

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.242

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.153

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.255

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.539

NRP_1Non-replicating persistence stage 1dosRassociated

-0.073

Amp0.2mg/mL AmpicillincellWall

0.646

Cephalexin20-100 ug/mL CephalexincellWall

-0.130

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.521

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.190

EMB10-20 ug/mL EthambutolcellWall

0.561

Eta12-40 ug/mL EthionamidecellWall

1.143

INH0.2-0.4 ug/mL IsoniazidcellWall

0.148

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.095

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.100

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.759

BZA0.12 mg/mL BenzamidearomaticAmides

-0.323

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.380

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.917

H2O24 mM hydrogen peroxideDNAdamaging

1.868

Levo10 ug/mL LevofloxacinDNAdamaging

0.773

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.638

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.997

Oflox5-10 ug/mL OfloxacinDNAdamaging

2.161

UVUV-irradiationDNAdamaging

-0.383

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.114

Antimycin12.5-50 ug/mL Antimycin A?

-1.127

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.183

PA_110-50 ug/mL Antitubercular compound PA-1?

0.393

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.320

PA8240.2-2 ug/mL PA-824?

1.017

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.614

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.407

Verapamil50 uM Verapamil?

-1.475

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.412

methoxatin10-20 ug/mL Methoxatin?